Cited by 179Cell death mechanisms and regulationMitochondrial Function and PathologyIon channel regulation and function

Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein

Open access
Arbel, Nir, Ben-Hail, Danya, Shoshan-Barmatz, Varda·2012·Journal of Biological Chemistry

Abstract

The mitochondrial protein, the voltage-dependent anion channel (VDAC), is implicated in the control of apoptosis, including via its interaction with the pro- and antiapoptotic proteins. We previously demonstrated the direct interaction of Bcl2 with VDAC, leading to reduced channel conductance. VDAC1-based peptides interacted with Bcl2 to prevent its antiapoptotic activity. Here, using a variety of approaches, we show the interaction of the antiapoptotic protein, Bcl-xL, with VDAC1 and reveal that this interaction mediates Bcl-xL protection against apoptosis. C-terminally truncated Bcl-xL(Δ21) interacts with purified VDAC1, as revealed by microscale thermophoresis and as reflected in the reduced channel conductivity of bilayer-reconstituted VDAC1. Overexpression of Bcl-xL prevented staurosporine-induced apoptosis in cells expressing native VDAC1 but not certain VDAC1 mutants. Having identified mutations in VDAC1 that interfere with the Bcl-xL interaction, certain peptides representing VDAC1 sequences, including the N-terminal domain, were designed and generated as recombinant and synthetic peptides. The VDAC1 N-terminal region and two internal sequences were found to bind specifically, and in a concentration- and time-dependent manner, to immobilized Bcl-xL(Δ21), as revealed by surface plasmon resonance. Moreover, expression of the recombinant peptides in cells overexpressing Bcl-xL prevented protection offered by the protein against staurosporine-induced apoptosis. These results point to Bcl-xL acting as antiapoptotic protein, promoting tumor cell survival via binding to VDAC1. These findings suggest that interfering with Bcl-xL binding to the mitochondria by VDAC1-based peptides may serve to induce apoptosis in cancer cells and to potentiate the efficacy of conventional chemotherapeutic agents. Background: Bcl-xL is overexpressed in cancer, contributing to resistance to chemotherapy. Results: Bcl-xL directly interacts with VDAC1 to mediate its antiapoptotic activity, activity that can be prevented by VDAC1-based peptides. Conclusion: Bcl-xL regulates apoptosis through direct interaction with VDAC1. Significance: Interfering with the interaction of Bcl-xL with VDAC1 can lead to apoptosis and potentiate the efficacy of conventional chemotherapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112.345918

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The N-terminal domain of VDAC1 interacts with several Bcl-2 family proteins that regulate apoptosis and is involved in gating the channel.

    “The N-terminal domain of VDAC1 interacts with several Bcl-2 family proteins that regulate apoptosis and is involved in gating the channel [96,97,98,99,100,101].”

    From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [101]

    The Results section on N-terminally truncated VDAC1 reports that its N-terminal region interacts with Bcl-xL and that removing it abolishes voltage-dependent conductance, supporting a role in channel gating. The paper also reports interactions between VDAC1 and other Bcl-2 family proteins, but the cited passages do not establish that the N-terminal domain interacts with several of them. No page number is available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arbel, N., Ben-Hail, D., & Shoshan-Barmatz, V.
Affiliations
Ben-Gurion University of the Negev (IL)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-06
Volume
287
Issue
27
Pages
23152-23161
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1990891202
Cited by
179
References
61
Citations by year
2026: 6 · 2025: 14 · 2024: 8 · 2023: 7 · 2022: 4 · 2021: 13 · 2020: 11 · 2019: 7 · 2018: 17 · 2017: 20 · 2016: 15 · 2015: 14 · 2014: 23 · 2013: 14 · 2012: 5
FWCI
7.19
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Keywords
Bcl-xL, VDAC1, voltage-dependent anion channel, apoptosis, anti-apoptotic effects, protein-protein interaction, staurosporine-induced apoptosis, cancer chemotherapy resistance, tumor cell survival
MeSH terms
Humans, Mitochondria, Neoplasms, Peptide Fragments, Apoptosis, Protein Structure, Tertiary, Drug Resistance, Neoplasm, Surface Plasmon Resonance, RNA, Small Interfering, Voltage-Dependent Anion Channel 1, bcl-X Protein, Protein Interaction Domains and Motifs, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review